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Conformational stabilityG protein-coupled receptors (GPCRs) are integral membrane proteins involved in cellular signaling and consti-
tute major drug targets. Despite their importance, the relationship between structure and function of these re-
ceptors is not well understood. In this study, the role of extracellular disulﬁde bonds on the trafﬁcking and
ligand-binding activity of the human A2A adenosine receptorwas examined. To this end, cysteine-to-alaninemu-
tations were conducted to replace individual and both cysteines in three disulﬁde bonds present in the ﬁrst two
extracellular loops. Although none of the disulﬁde bonds were essential for the formation of plasmamembrane-
localized active GPCR, loss of the disulﬁde bonds led to changes in the distribution of the receptor within the cell
and changes in the ligand-binding afﬁnity. These results indicate that in contrast to many class A GPCRs, the ex-
tracellular disulﬁde bonds of the A2A receptor are not essential, but can modulate the ligand-binding activity, by
either changing the conformation of the extracellular loops or perturbing the interactions of the transmembrane
domains.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
G protein-coupled receptors (GPCRs) are heptahelical, integral
membrane proteins involved in signal transduction. Because of their lo-
cation at the plasma membrane and their importance in cellular signal-
ing, GPCRs constitute major drug targets. Approximately 36% of drugs
on the market are known to interact with GPCRs [1]. The adenosine re-
ceptors (A1, A3, A2B andA2A) aremembers of the family AGPCRs, and are
ubiquitously expressed throughout the human body. This subfamily is
one of themain targets for the treatment of neurodegenerative diseases,
diabetes, cancer and heart disease [2].s, adenosine receptors; ECL, ex-
rotein; A2AR, A2A receptor;WT,
rane; HR, Hausdorff ratio; HEK
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proximately 40%,with the highest sequence identity betweenA2A andA2B
(46%), and A1 and A3 (46%) [3]. Despite the high sequence homology, the
ARs have distinct afﬁnities for various ligands and couple to different G
proteins,whose activation regulates differentmembrane and intracellular
proteins (e.g. adenylyl cyclase, Ca2+ channels, K+ channels, andphospho-
lipase C) [4]. Out of the four ARs, only the A2A receptor (A2AR) expresses at
high levels in heterologous systems [5] and has been extensively studied
in biophysical and structural studies [6–13].
The crystal structure of A2AR identiﬁed three disulﬁde bonds
between extracellular loop 1 (ECL1) and ECL2 of the receptor [10]. It is
speculated that this extensive disulﬁde bond network forms a rigid
structure exposing the ligand-binding pocket [10]. One of the three di-
sulﬁde bonds is highly conserved among many class A GPCRs [3,10,
14], and numerous studies indicate that this disulﬁde bond is critical
for the structural stability, expression, and function of GPCRs [14,15].
Mutations to the conserved cysteines have shown that this covalent
linkage between ECL1 and ECL2 is critical for maintaining the high-
afﬁnity ligand-binding conformation of the thyrotropin-releasing
hormone receptor [16], rhodopsin [17,18], μ opioid receptor [19], β2
adrenergic receptor [20,21], and A1 adenosine receptor [22], to name a
few. For some GPCRs, mutating the extracellular cysteines also resulted
in lower protein expression levels or reduced/abolished trafﬁcking of
Table 1
List of the Cys-to-Ala constructs created to test the role of the disulﬁde bonds in the A2A
adenosine receptor.
Cysteine-to-alanine constructs
Single Cys-to-Ala constructs Double Cys-to-Ala constructs
ECL1 ECL2 ECL1 and ECL2
C71A C146A C71A–C159A
C74A C159A C74A–C146A
C77A C166A C77A–C166A
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conserved cysteines in μ opioid receptor reduced the number of re-
ceptors present at the plasma membrane compared to the wild type
[19]. In contrast, mutations of the cysteines in ECL1 or ECL2 of the A1
adenosine receptor resulted in a loss of receptors at the cell surface
[22]. In the aforementioned examples, the conserved disulﬁde bond
is the only covalent link between ECL1 and ECL2, and disruption of this
link likely affected the topology of the ECLs and thus the ligand-binding
afﬁnity.
Previously, the role of the disulﬁde bonds in the A2A adenosine re-
ceptor has been investigated using reducing agents. Dithiothreitol
(DTT) treated A2AR displayed reduced activity compared to the wild
type A2AR [6,23]. In this study,we used amutational approach to evaluate
the role of the disulﬁde bond network of the humanA2AR for contributing
to the ligand-binding capability and the exceptional expression levels that
have been previously described [7,24,25]. To this end, systematic muta-
tions of the cysteineswere conducted, revealing that the conserved disul-
ﬁde bond was not essential for the trafﬁcking and ligand-binding activity
of this receptor. On the contrary, mutations to the cysteines in the ECLs of
the A2AR resulted in a range of ligand-binding afﬁnities and trafﬁcking
patterns.2. Results
Disulﬁde bonds have been shown to have a critical role in protein
stability, trafﬁcking and function formanyGPCRs [14–21]. To character-
ize the role of the speciﬁc disulﬁde bonds in A2AR,we created Cys-to-Ala
mutations in the three disulﬁde bonds that join ECL1 and ECL2 (Fig. 1).Fig. 1.Crystal structure of A2AR bound to an antagonist, ZM241385 [10]. The cysteines that
form the disulﬁde bonds are color coded in green, red and blue. Adapted using PyMOL
(The PyMOL Molecular Graphics System, Version 1.3 Schrödinger, LLC), Protein Data
Bank identiﬁcation code 3EML.Six single Cys-to-Ala and three double Cys-to-Ala constructswere creat-
ed as outlined in Table 1.
2.1. Trafﬁcking patterns and ﬂuorescent-ligand binding of A2AR wild type
and Cys-to-Ala variants
The constructs listed in Table 1 were transfected and expressed in
HEK-293 cells as described in the Materials and methods section to
test how the Cys-to-Ala mutations affected the trafﬁcking of the recep-
tor and ligand-binding activity. Trafﬁcking refers to the receptor move-
ment within the cell, including insertion of new receptors into the
plasmamembrane, internalization, recycling, and sorting of internalized
receptors to lysosomes for degradation [26]. For these studies, the A2AR
constructs were C-terminally tagged with the cyan ﬂuorescent protein
(CFP), and trafﬁcking to the plasma membrane was analyzed by CFP
ﬂuorescence detection at the periphery of the cell via confocalmicrosco-
py. Fig. 2 displays the typical trafﬁcking pattern of the wild type (WT)
A2AR; a strong halo is seen at the periphery of the cell, indicating that
the receptor trafﬁcked well to the plasma membrane.
The typical expression patterns of all the Cys-to-Ala variants are
displayed in Fig. 3. From these images, it appears that all A2AR variants
trafﬁcked to the plasma membrane. However, it is also evident that the
internally-localized receptor population differs between the variants
and the WT A2AR.
From these images, it is not clear whether receptors present within
the cell are retained in the endoplasmic reticulum (ER), in lysosomes
for degradation, or are en route to the plasma membrane. However, as
our focus was on proper localization of active receptor to the plasma
membrane, we used the followingmethods to characterize the distribu-
tion of the receptors between the plasmamembrane versus ER, and the
activity of the receptor once it reached the cell surface:
1) Comparison of the distribution of the A2AR variants at the plasma
membrane and at the ER using plasma membrane and ER dyes
2) Fluorescent–ligand (FITC-APEC) binding to further test if the recep-
tor was at the plasma membrane and in its active form
Cells were stained with plasmamembrane (M) and ER dyes to com-
pare localization of A2AR WT and the A2AR variants. At least twenty im-
ages for each A2A variant were analyzed using the Hausdorff ratio (HR),
which is deﬁned as the directed Hausdorff distance between the CFP
tagged receptor and the plasma membrane divided by the directed
Hausdorff distance between the ER and the plasma membrane, as de-
scribed in the Materials and methods section. When this ratio is low
(b0.5), it indicates that the receptor was localized primarily at the plas-
ma membrane. Ratios close to one indicate that there was a higher ER-
localized receptor population. Fig. 4 displays two examples of disparate
receptor trafﬁcking; the top image represents a cell where most of the
receptor trafﬁcked to the plasmamembrane, and the bottom image rep-
resents a cell with higher levels of ER localized receptor. This difference
can be seen by the clear outline of CFP at the cell periphery in Fig. 4A
compared to the diffuse CFP ﬂuorescence throughout the ER network
in Fig. 4D. Comparison of the CFP ﬂuorescence (Fig. 4A and 4D) to that
of the plasma membrane dye (Fig. 4B or 4E, respectively) versus that
Fig. 2. Trafﬁcking pattern of WT A2AR and negative control. HEK-293 cells transiently transfected with wild type A2A–CFP (left) and with an empty plasmid as a negative control (right).
Scale bars, 10 μm.
Fig. 3. Trafﬁcking patterns of A2AR Cys-to-Ala variants. HEK-293 cells transiently transfected with A2AR-CFP constructs. A–C) A2AR variants with mutations in the cysteines in ECL1. D–F)
Variants with mutations in the cysteines in ECL2. G–I) Variants with mutations in the cysteines in ECL1 and ECL2 that correspond to the disulﬁde bonds. Scale bars, 10 μm.
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Fig. 4. Analysis of receptor distribution within the plasma membrane and ER for two disparate examples. To quantify the receptor distribution within the cell, HEK-293 cells were tran-
siently transfected with A2AR–CFP constructs. Cells were stained using WGA plasma membrane dye (pseudocolored in red; B and E) and with ER tracker dye (pseudocolored in green;
C and F). Images A–C are representative of a variant that trafﬁcked to the plasma membrane, C74A–C146A; images D–F are representative of a variant that displayed a high ER localized
receptor population, C146A. The Hausdorff distance ratios were determined as described in theMaterials andmethods section, and are shown to the right of the images. Scale bars, 10 μm.
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brane dye conﬁrms this analysis. Quantitatively, these observations
are reﬂected in the Hausdorff ratios of 0.1 for the variant that trafﬁcked
mostly to the plasma membrane, and 0.8 for the variant with higher
levels of ER-localized receptor.
This semi-quantitative method identiﬁed three different trafﬁcking
patterns: a higher ER retention relative to the WT A2AR — all the single
Cys-to-Ala variants and the conserved disulﬁde bond variant (C77A–
C166A); a similar trafﬁcking pattern as the WT A2AR — C71A–C159A;
and improved plasmamembrane trafﬁcking relative to theWT receptor
— C74A–C146A. These different trafﬁcking patterns are highlighted in
the box plot, Fig. 5, where the gray circles indicate the Hausdorff dis-
tance ratios for individual images of theWT and the Cys-to-Ala variants.
The average values for the wild type A2AR and the Cys-to-Ala variants
and the 95% conﬁdence interval are listed in Table 2.
The box plot highlights the wide range of receptor distribution
observed for some of the A2AR variants; images representative of the
low and the high Hausdorff ratios for each variant are shown in the
Supplemental information. Analysis of the average pixel intensity, an in-
dicator of the protein expression levels per cell, revealed that there is no
correlation between the WT expression levels per cell and the receptor
distribution within the cell as indicated by the Hausdorff ratio analysis
(Supplemental information).
Like the WT receptor, all the A2AR variants appeared to trafﬁc to the
plasma membrane to some degree. To determine if the variants were
able to bind ligand, a high afﬁnity (KD = 57 nM) ﬂuorescent agonist,
FITC-APEC [27], was used to visualize the active receptors at the cell sur-
face. For these experimentswe usedHEK-293 cells expressing untagged
A2AR variants; Fig. 6 shows the FITC-APEC binding typically observed.
This ﬂuorescent ligand-binding study showed that all single and
double Cys-to-Ala variants were capable of binding the ﬂuorescent li-
gand (Fig. 6). This result is consistent with the observation that the sin-
gle and double Cys-to-Ala variants trafﬁcked to the plasma membrane
and conﬁrms their ligand-binding capability.2.2. Saturation binding of [3H] CGS 21680 to A2AR wild type and Cys-to-Ala
variants
Radioactive ligand binding was conducted to determine the binding
afﬁnity of the A2AR variants for the high-afﬁnity agonist [3H] CGS 21680
(Fig. 7). HEK-293 cells transiently transfected with the untagged A2AR
constructs were incubated with increasing amounts of [3H] CGS 21680
and bound ligand was measured, as described in the Materials and
methods section.
Bound receptor–ligand complexes are plotted versus increasing li-
gand concentration for single and double Cys-to-Ala variants (Fig. 7A),
where a line shows the ﬁt to a single-site binding model. The equilibri-
um dissociation constant (KD) and the total number of active receptors
per cell (Rmax) were determined from this ﬁt (Table 3).
Normalizing the data using the Rmax values calculated from the ﬁts
allows for easier visualization of changes in the ligand-binding afﬁnity
(KD), as shown in Fig. 7B. Linear transformations of the data (Scatchard
analysis, Fig. 7C) highlight that the single cysteine variants – in particu-
lar mutations in ECL2 – had the greatest impact on the total active
receptor at the plasma membrane (x-axis intercept). A Hill plot (not
shown) yields a Hill coefﬁcient equal to one, validating the use of a
monovalent binding model to ﬁt the data.
In this ligand-binding analysis, three populations with somewhat
different binding afﬁnities were identiﬁed, as follows (Table 3):
1) C74A–C146A had similar KD (92 nM) to the WT A2AR (94 nM). This
variant also had improved plasma membrane trafﬁcking relative to
the WT A2AR (Fig. 5).
2) Remarkably, the single Cys-to-Ala variants displayed modestly
increased ligand-binding afﬁnity compared to the WT receptor;
despite their improved ligand-binding afﬁnity, their higher levels
of ER localization are likely a result of exposure of a free cysteine in
the ECL.
Fig. 5.Receptor distributionwithin theplasmamembrane and ER forWTA2AR and theCys-to-Ala variants. TheHausdorff distance ratiowas calculated for at least twenty images for eachof
the A2AR variants, where the gray circles represent the values calculated for each image. Box plots were used to display the data, with red lines indicating themedian for each variant; the
edges of the blue boxes correspond to the 25th and 75th percentiles.
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their plasma membrane trafﬁcking, C77A–C166A and C71A–C159A
had signiﬁcantly higherKD values (lower afﬁnity) than theWT recep-
tor for CGS 21680.Table 2
Cellular distribution of the A2AR WT and Cys-to-Ala variants.
Receptor distribution: Hausdorff ratio
Mean ± SEM 95% CI Sample size
A2A WT 0.55 ± 0.02 0.50–0.60 62
C71A 0.92 ± 0.04 0.84–1.00 20
C74A 0.87 ± 0.02 0.82–0.92 22
C77A 0.80 ± 0.03 0.74–0.85 33
C146A 0.93 ± 0.02 0.88–0.98 43
C159A 0.66 ± 0.03 0.60–0.72 45
C166A 0.66 ± 0.02 0.61–0.71 41
C71A–C159A 0.53 ± 0.02 0.50–0.56 24
C74A–C146A 0.36 ± 0.02 0.32–0.41 39
C77A–C166A 0.78 ± 0.03 0.72–0.84 42
HEK-293 cells expressing CFP tagged A2ARWT and Cys-to-Ala variants, stained with plas-
ma membrane and ER dyes. The Hausdorff distances between CFP and the plasma mem-
brane, and ER and plasma membrane were calculated. The ratio of these distances
(mean ± SEM), the values obtained for the 95% conﬁdence interval, and the number of
cells used for this analysis are listed in the table.3. Discussion
Unlike other class A GPCRs, such as rhodopsin and the adrenergic
receptors, ECL2 of the A2A adenosine receptor is mainly unstructured,
with a rich disulﬁde bond network proposed to constrain the otherwise
ﬂexible ECL2 [10]. One of these disulﬁde bonds (C77–C166) is con-
served in the class A GPCRs; this disulﬁde bond is essential for the ex-
pression, membrane trafﬁcking and function of some GPCRs [14–21].
For example, for the closely related A1 adenosine receptor, mutation of
either cysteine of the conserved disulﬁde bond results in a complete
loss of antagonist binding and plasma-membrane localization [22]. In
contrast, by mutating the cysteines in ECL1 and ECL2, including those
of the conserved disulﬁde bond, we were able to access a range of
ligand-binding afﬁnities (from 52–150 nM) and only somewhat
reduced trafﬁcking to the plasma membrane. Unexpectedly, the con-
served cysteines (C77, C166) were not critical for the trafﬁcking and
ligand-binding activity of this receptor.
3.1. Trafﬁcking patterns and ER quality control
Tagging theWT receptor and the Cys-to-Ala constructs with CFP en-
abled us to conﬁrm that theA2AR variantswere expressed and trafﬁcked
to the plasma membrane (Fig. 2–3). Using the Hausdorff ratio (HR)
analysis, a clear difference between the distribution of theWT receptor,
with a HR of 0.55, and all the single Cys-to-Ala variants, with a HR range
Fig. 6. Fluorescent-ligand binding to the A2AR variants. HEK-293 cells transiently transfected with untagged A2AR constructs and incubated with 70 nM FITC-APEC. A–C) Variants with
mutations in the cysteines in ECL1. D–F) Variants with mutations in the cysteines in ECL2. G–I) Variants with mutations in the cysteines in ECL1 and ECL2, corresponding to the disulﬁde
bonds. J–K) WT A2AR and negative control. Scale bars, 10 μm.
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Cys-to-Ala variants have signiﬁcantly higher levels of ER-retained
receptor (Fig. 5 and Table 2).
Unpaired cysteine residues are one of the main features that are
recognized by the ER quality control system [28], in particular by thiol-
disulﬁde oxidoreductases. There are a high number of oxidoreductases
in the ER, and native and non-native disulﬁde bonds are transiently
formed in the ER until folding is complete [28,29]. Receptor trafﬁcking
to the plasma membrane was restored and even improved in most
of the double Cys-to-Ala variants, C71A–C159A (HR 0.53) and
C74A–C146A (HR 0.36). Thus, our data suggests that the unpaired
cysteines of the A2AR variants may interact with ER oxidoreductases,
and are retained in the ER due to disulﬁde bond shufﬂing until a
folded conformation is achieved.
In contrast to the other double cysteine variants, C77A–C166A (site
of conserved disulﬁde bond) had a higher level of ER localized receptor
(HR 0.78) compared to WT (0.55). It is unclear how the ER quality
control recognizes the differences in loop structure that form upon the
removal of the conserved disulﬁde bond, but not the removal of theother two non-conserved disulﬁde bonds. Investigating thismechanism
could lead to an improved understanding of the molecular factors re-
sponsible for the distribution of GPCRs within the cell, and should be
further investigated. These studies could also be expanded to study
the effect of double disulﬁde bond mutations on the trafﬁcking and
ligand-binding activity of the human A2AR.
3.2. Receptor ligand-binding activity and thermodynamic stability
Even though the single Cys-to-Ala variants exhibited higher levels of
ER localized receptors compared to the WT, they were able to bind ﬂuo-
rescent and radiolabeled ligands with afﬁnity close to WT (Fig. 6A–F
and 7). It is possible that these variants could still form two disulﬁde
bonds between ECL1 and ECL2, achieving a non-native conformation
with higher afﬁnity to the ligand than the WT receptor (Fig. 7B and
Table 3).
Our data suggest that only two disulﬁde bonds are needed to main-
tain the WT conformation of A2AR. Mutations to C71–C159 and C77–
C166 had a somewhat negative impact on the ligand-binding afﬁnity
Fig. 7. Equilibrium saturation data of [3H] CGS 21680 binding to A2AR variants expressed in HEK-293 cells. A) Monovalent binding ﬁt: the data points are the average of at least two inde-
pendent experiments performed in triplicate. The total number of active receptors per cell (Rmax) and the equilibrium dissociation constant (KD) values are displayed in Table 3.
B) Normalized monovalent binding ﬁt: data were normalized using the Rmax value. C) Scatchard analysis: the Scatchard analysis of [3H] CGS 21680 saturation binding to HEK-293 cells
expressing the A2AR variants was conducted according to Scatchard [43]. For the single Cys-to-Ala variants, only C71A and C159A are plotted for clarity, and dashed lines represent the
ﬁts to the data. Data for the double Cys-to-Ala variants are plotted using downward-pointing triangles and solid lines for the ﬁts. The data for the WT A2AR are plotted using asterisks
and a black solid line for the ﬁt.
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on ligand afﬁnity, further suggesting that this disulﬁde bond is not
necessary for the folding and ligand-binding activity of this receptor.
However, this disulﬁde bond could be important for the interactionsTable 3
Binding parameters of A2AR WT and Cys-to-Ala variants.
Equilibrium binding studies
KD ± SEM
(nM)
KD 95% CI
(nM)
Rmax ±
SEM ×106
Rmax %
of A2AR
Sample
size
A2A WT+ 94.5 ± 9.5 75.8–113.1 2.9 ± 0.6 100 12
C71A+ 61.5 ± 11.1 39.8–83.2 0.64 ± 0.14 22.2 6
C74A+ 60.7 ± 3.6^ 53.7–67.7 1.1 ± 0.1 38.5 6
C77A+ 70.0 ± 14.3 42.0–98.0 0.54 ± 0.13 18.8 9
C146A+ 51.7 ± 6.3^ 39.3–64.2 0.18 ± 0.03 6.4 9
C159A* 49.8 ± 20.9 8.7–90.8 0.16 ± 0.01 5.6 6
C166A+ 64.4 ± 3.1^ 58.4–70.4 0.44 ± 0.12 15.3 6
C71A–C159A+ 149.8 ± 5.0^ 140.0–159.6 1.3 ± 0.2 44.1 6
C74A–C146A+ 91.8 ± 15.4 61.7–121.9 1.5 ± 0.1 50.9 9
C77A–C166A+ 139.8 ± 8.9^ 122.3–157.3 1.6 ± 0.05 54.4 6
HEK-293 cells expressing untagged A2AR WT and Cys-to-Ala variants were incubated
with increasing amount of agonist [3H] CGS 21680. Equilibriumdatawere ﬁt to amonova-
lent binding model to determine the total number of active receptors (Rmax) and the
equilibrium dissociation constant (KD). (+) r2 values N 0.9, and (*) r2 values N 0.84.
Values represent the mean ± the standard error of the mean (SEM) for at least two
independent biological experiments performed in triplicate. Sample size indicates the
number of replicates measured. (^) Indicates KD values signiﬁcantly different from the
wild type value, p ≤ 0.05.with other ligands not tested in the current study (e.g. antagonists
and other agonists).
Earlier in vitro studies of A2AR, where puriﬁed receptors were dena-
tured using urea, showed that WT receptor and DTT-reduced receptor
underwent a similar unfolding transition; however, ligand binding
was signiﬁcantly decreased in the DTT-reduced receptor [6]. Taken to-
gether with our in vivo studies, these data indicate that the disulﬁde
bond network in A2AR is more critical for maintaining the active confor-
mation of the receptor than for achieving a more stable structural con-
formation [6]. A similar role may be implicated in another GPCR, the
human P2Y12 receptor, for which no electron density was found in the
X-ray structure, suggesting that a labile or dynamic disulﬁde bond
forms between the conserved cysteines [30]. Additionally, mutations
to the conserved cysteines retained similar protein yield and stability,
indicating that for P2Y12 the conserved disulﬁde bond serves a functional
role [30].
It has been reported that the recognition of misfolded proteins by
the quality control system in the ER is correlated with the thermody-
namic stability of the protein or altered folding kinetics [28,31,32].
Since mutation to C74–C146 improved the receptor trafﬁcking to the
plasma membrane (Fig. 5 and Table 2), it is possible that in this case
the removal of the disulﬁde bond between C74 and C146 improved re-
ceptor stability, assembly efﬁciency, and thus, trafﬁcking. Our results
suggest that in A2AR the disulﬁde bonds restrict the active conformation
of the receptor. However, this constrained active conformation may not
be the most stable conformation, as seen with the loss of the C74–C146
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planation that is consistent with our results is that during evolution
A2AR was optimized for function rather than for folding and assembly,
as previously suggested by Ellgaard andHelenius to explain thepoorna-
tive trafﬁcking efﬁciency of some proteins, including CFTR and the δ opi-
oid receptor [28].
The range of ligand-binding afﬁnities observed with the A2AR vari-
ants (52–150 nM) suggests that the individual cysteines and disulﬁde
bonds are not critical for the ligand-binding activity of this receptor, per-
haps because the disulﬁde bond network in A2AR provides some struc-
tural redundancy. Alternatively, this modest impact on afﬁnity could
indicate a larger tolerance for various ligand-binding conformations. It
is unclear whether the disulﬁde bond network is important to maintain
the active conformation of the ECLs, or of residues in the transmem-
brane domains encompassing the ligand-binding pocket.
4. Importance of disulﬁde bonds on ligand recognition
There is growing evidence that ECL2 is important for ligand recog-
nition in class A GPCRs [14]. In many GPCRs, this region is not well con-
served in length, amino acid composition, and number of disulﬁde
bonds [15,33]. In contrast, there exists high structural similarity among
GPCR transmembrane domains [3]. This can be observedwithin the aden-
osine receptor (AR) family, which share high sequence homology of the
residues in the transmembrane domains, with low homology in the ECL
regions, as seen in Fig. 9. It has been postulated that interactions that de-
termine AR subtype selectivity are localized to the more diverse upper
and extracellular regions of the binding pocket [34]. In contrast, the
lower portion of the ligand-binding pocket is believed to determine the
strength of ligand binding [35].
From theA2AR crystal structures, NMR,molecularmodeling andmu-
tagenesis studies, the details of the ligand-binding pocket of the ARs areFig. 8. Residues in ECL2 important for ligand recognition and binding. Cysteines are indicated a
important for ligand binding are indicated as sticks. Adapted using PyMOL, Protein Data Bankbecoming clearer. In A2AR, ECL2 forms a random coil structure with a
very short α-helical segment at the end of the loop [3]. This segment
could form critical aromatic π-stacking interactions between F168 and
the heterocyclic core of various A2AR agonists and antagonists [3,8,11,
13,35–37]. Additionally, this small α-helical segment contains E169
that could form important polar interactions with various ligands and
with H264 in ECL3 [37]. ECL2 has another α-helical segment, above
F168 and E169, Fig. 8. This helix contains the positively charged residues
K150 and K153, which can play a role in the initial recognition of the li-
gand and its movement to the binding site ([37] and supplement of Ref.
[12]). Supervised molecular dynamics (SuMD) has allowed examina-
tion of the ligand–receptor recognition pathway on a nanosecond
time scale. This approach also highlighted the role of ECL2 in ligand rec-
ognition of human A2A adenosine receptor [38]. Additionally, in molec-
ularmodeling studies, the carboxyl group of the agonist CGS 21680 is in
contact with K153 through ionic interactions [37].
Our data suggest that only two disulﬁde bonds are needed to retain
WT ligand-binding afﬁnity, C71–C159 and C77–C166, and therefore
these two disulﬁde bonds may be critical for restricting the conforma-
tion of the two helices in the ECL2. Furthermore, mutations to C71–
C159 and C77–C166 had the highest impact on the ligand-binding afﬁn-
ity of A2AR, which could be due to an increased ﬂexibility of ECL2 in the
absence of these disulﬁde bonds, resulting in a conformation where
F168, E169, K150 and K153 are not in direct contact with the ligand. It
is likely that the disulﬁde bonds restrict the conformation of the ECLs,
and that for the incoming ligand, each ECL topology represents a signa-
ture for each receptor [19].
The four ARs contain a conserved phenylalanine (F168) residue in
ECL2, and E169 is conserved in A2AR, A2BR and A1R, as seen in Fig. 9.
Therefore, these residues could also form important contacts with the
ligand in the other ARs. A1R and A3R have only the one conserved disul-
ﬁde bond linking ECL1 and ECL2. A2BR has a rich concentration ofs spheres, and color-coded to note the corresponding disulﬁde bonds. Residues in the ECLs
identiﬁcation code 4EIY.
Fig. 9. Sequence alignment of the human adenosine receptors. The yellow highlight denotes the approximate boundary of the extracellular loops, and the cysteines in ECL1 and ECL2 are
highlighted in blue. Asterisks indicate fully conserved residues, colons indicate conservation between groups of strongly similar properties, and periods indicate conservation between groups
of weakly similar properties. UniProt was used for sequence alignment.
[44].
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and ECL2. Since the disulﬁde bond network is different among the ARs,
the interactions between the residues important for ligand binding (e.g.
F168 and E169) and the ligand could vary due to a difference in loop to-
pology, restricted by the disulﬁde bonds. The different disulﬁde bond
networks present in the ARs could help explainwhy theARs have differ-
ent afﬁnities for the same ligand.
5. Conclusion
The ECL regions are challenging to capture in crystal structures due
to their ﬂexibility; therefore,mutagenesis and functional studies contin-
ue to provide insights into the importance of these ﬂexible regions. Our
results suggest that the disulﬁde bond network in A2AR is important for
maintaining the topology of the ECLs. By mutating the cysteines in the
ECLs, wewere able to access amodest range of ligand-binding afﬁnities,
perhaps indicative of various ligand-binding conformations.
None of the cysteine residuesmutated in this study, including the con-
served cysteines,were essential forA2A adenosine receptor trafﬁcking and
ligand-binding activity. Our results also indicate that the disulﬁde bondnetwork does not contribute to the assembly of the most stable confor-
mation, as the removal of C74–C146 improves folding efﬁciency and traf-
ﬁcking to the plasma membrane, attributes that have been linked to
conformational stability. This suggests that a widely accepted concept in
thebiophysical community, that disulﬁdebonds contribute to protein sta-
bility, may not always be the case, in particular with proteins with an ex-
tensive disulﬁde bond network, such as A2AR.
6. Materials and methods
6.1. Mutagenesis and cloning
Human A2AR cDNA was a kind gift from Dr. Marlene Jacobson
(Merck). Oligonucleotides used for site-directed mutagenesis and clon-
ing were obtained from IDT (Coralville, Iowa), and are listed in the Sup-
plemental information. All enzymeswere purchased fromNew England
Biolabs (Ipswich, MA). All the site-directed cysteine-to-alanine muta-
tions were introduced in the A2AR gene using the pcDNA 3.1 vector
and the Quick-change II XL Kit (Agilent Technologies, Santa Clara, CA),
following the manufacturer's protocol. The full-length A2AR coding
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cyan ﬂuorescent protein (CFP) for mammalian expression. KpnI and
XhoI restriction enzymes were used for subcloning the A2A gene into
pCEP4.
Escherichia coli strain DH5αwas used for propagation of the cloning
plasmids using Luria–Bertani media supplemented with 100 μg/ml am-
picillin; cultures were incubated overnight at 37 °C and 250 rpm. Trans-
formations of E. coli were performed by the heat shock method [39].
DNA was extracted from DH5α using the Wizard Plus SV Minipreps
DNA Puriﬁcation System from Promega (Madison, WI). All mutations
were conﬁrmed by DNA sequencing (DNA Core Facility, University of
Delaware).
6.2. Cell culture and transfection
All media used for mammalian cell culture and Lipofectamine2000
were purchased from Life Technologies (Grand Island, NY). HEK-293
cells were grown in Dulbecco's Modiﬁed Eagle's Medium (DMEM)
supplemented with 10% fetal calf serum at 37 °C in a humidiﬁed 5% CO2
incubator. Transient transfections were carried out using Lipofecta-
mine2000 following the manufacturer's instructions and 800 ng of DNA
per 80% conﬂuent T-25 culture ﬂask.
6.3. Expression and trafﬁcking patterns
In order to conﬁrm the expression and monitor the trafﬁcking
patterns, the A2AR constructs utilized for these studies contained a
C-terminal-linked CFP. HEK-293 cells were imaged 36 h after transfec-
tion. For imaging, cells were seeded at 100,000 cells per well (Nunc
Lab-Tek II Chambered Cover Glass 4-well, Thermo Scientiﬁc) and
allowed to adhere overnight. Transfection efﬁciency was monitored
using the CFP-tagged receptors; the efﬁciency was uniform throughout
the experiments, ranging from 40%–46%.
6.4. Plasma membrane and endoplasmic reticulum (ER) staining
To further characterize the trafﬁcking patterns of the A2AR–CFP
constructs, plasmamembrane (WGAAlexa Fluor 555 Conjugate,Molec-
ular Probes, Eugene, OR) and endoplasmic reticulum (ER Tracker Green,
Molecular Probes) dyes were used. For the staining experiments,
transfected cells were plated at 100,000 cells per well in a 4-well imag-
ing chamber (Nunc Lab-Tek II Chambered Cover Glass, Thermo Scientif-
ic) coated with 12% (w/v) collagen. Cells were incubated at 37 °C in a
humidiﬁed 5% CO2 incubator overnight. The next day the cells were
washed once with PBS. All aspirations and additions to the imaging
wells were performed drop-wise using gel-loading tips. 400 μL of the
ER Tracker Green solution (1 μM in PBS) was added to each well, and
the plates were incubated for 20 min at 37 °C. 200 μL of the WGA solu-
tion (2 μg/ml in PBS) was then added to each well without aspirating
the ER Tracker Green solution. The plates were incubated for an addi-
tional 5 min at 37 °C, and the dye solutions were removed following
this incubation. Next, 400 μL of 4% paraformaldehyde (in PBS) was
added to each well and the plates were incubated for 10 min at 37 °C.
After this incubation, the paraformaldehyde solution was removed,
the wells were washed twice with 400 μL PBS and a ﬁnal volume of
400 μL PBS was added to each well for imaging. Cells were imaged
48 h after transfection.
6.5. Fluorescent ligand binding
For ligand binding studies, untagged receptors were used (A2A
constructs in pCEP4 vector). Transfected HEK-293 cells were plated
at 100,000 cells per well in a 4-well imaging chamber and grown over-
night. Media was removed and replaced with 70 nM FITC-APEC (NIMH
synthesis program, http://nimh-repository.rti.org, NIMH Code: D-906)in PBS and incubated for 1 h at 37 °C in a humidiﬁed 5% CO2 incubator.
Cells were imaged 36–48 h after transfection.
6.6. Confocal microscopy
Confocal images were acquired on an inverted Zeiss LSM 510 NLO
laser-scanning microscope (Carl Zeiss, Inc., Germany) using a 25 mW
Argon laser (LASOS, Ebersberg, Germany) and a 40× Plan-Neoﬂuar/1.3
Oil DIC objective lens (Carl Zeiss, Inc.).
6.7. Analysis of receptor trafﬁcking
Images of cells expressing the A2AR–CFP constructs, stained with the
plasmamembrane and ER dyeswere analyzed in order to determine the
distribution pattern of the different A2A variants. For this purpose, while
imaging, themaster gain (800–900) and the laser powerwere kept con-
stant. The quality of the ER and plasmamembrane stainswas conﬁrmed
prior to inclusion in analysis; i.e., images where the plasma membrane
dye stained the membranes of internal organelles were not used in
the analysis. Images were cropped to include only one cell per ﬁle
prior to the analysis.
Each ﬁle was composed of an aligned set of three 12-bit gray scale
images: the CFP-tagged receptor, the plasma membrane, and the ER.
See Fig. 4 for examples; in this case, the CFP-tagged receptor is shown
in cyan, the plasma membrane in red, and the ER in green to facilitate
identiﬁcation of the structures. For analysis, each image was subjected
to thresholding to separate signal from background pixels, resulting in
binary images. We used the IsoData auto-thresholding algorithm [40]
that is the default thresholding algorithm in ImageJ [41]. Let SCFP, SM
and SER be the set of signal pixels in the CFP-tagged receptor image,
the plasma membrane image, and in the ER image, respectively. In
order to compare the shape of those three point sets, we used the direct-
ed Hausdorff distance H(A,B) between two point sets A and B in the
plane, which is deﬁned as follows [42]:
H A;Bð Þ ¼ maxa∈A minb∈B a−bk k|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
nearest neighbor
;
where ‖a− b‖ denotes the Euclidean distance between points a and b.
The directed Hausdorff distance assigns to every point a in A its nearest
neighbor in B, and then computes the maximum of all distances
between assigned points. In order to make this distance more robust
against noise and outliers causing non-representative large distances,
we replace themaximumwith an average and arrive at themodiﬁed di-
rected Hausdorff distance:
H

A;BÞð ¼ averagea∈A minb∈B a−bk k :
Our goal was to quantify whether the shape of SCFPwas closer to the
membrane shape of SM or to the shape of the cell interior that is repre-
sented by SER. We therefore compared SCFP to SM and SER to SM using the
modiﬁed directed Hausdorff distance, and combined both quantities in
a single Hausdorff ratio (HR):
HR SC FP ; SM ; SERð Þ ¼
eH SC FP ; SMð Þ
eH SER; SMð Þ
:
A large Hausdorff ratio (close to 1) indicates that the shape of SCFP
was similar to SER, as the average distances to the plasma membrane
are similar. A small Hausdorff ratio (b0.5) indicates that the shape of
SCFP was more similar to the membrane shape SM, as the average dis-
tances from the CFP-tagged receptor to the plasmamembrane are over-
all smaller than the average distances from the ER to the plasma
membrane. Due to the use of average distances as well as the use of a
ratio, the Hausdorff ratio is quite robust and works well with different
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tion in ImageJ [41].
6.8. Radioligand binding
Radioligand binding was performed as described previously [7].
HEK-293 cells were transfected with untagged receptors (A2A constructs
in pCEP4), and tested for ligand binding 48 h after transfection. Cells
fromone conﬂuent T-25 ﬂaskwerewashed and resuspended in the bind-
ing buffer (TME: 50 mM Tris–HCl, 10 mM MgCl2 and 1 mM EDTA).
Cells were then aliquoted (approximately 100,000 cells per well) into
poly(ethyleneimine) (0.1% v/v) treated 96-well glass ﬁber ﬁlter plates
(MultiScreen-FC ﬁlter type B, Millipore, Billerica, MA). Cells were then in-
cubated with 0 nM–470 nM [3H] CGS 21680 (Perkin Elmer, Boston, MA)
for 3 h. The binding reaction was terminated by ﬁltration, with three
washes of ice-cold TME buffer. 30 μL of scintillation solution (ULTIMA
Gold, Perkin Elmer) was added to each well. Ligand binding was deter-
mined via bound radioactive counts (CPMs) using a Perkin-Elmer 1450
Microbeta liquid scintillation counter. Multiple counts were taken until
the values stabilized, approximately 24 h after the addition of the scintil-
lation solution. Non-speciﬁc bindingwas determined in parallel reactions
using non-transfectedHEK-293 cells incubated over the same ligand con-
centrations. All samples were run in triplicate and at least two indepen-
dent biological experiments were conducted. Non-speciﬁc binding was
subtracted from the total binding to determine the speciﬁc binding.
Matlab (version 7.10, MathWorks, Natick, MA) was used to ﬁt the data
to the equilibrium solution of the mass action kinetic model for a single-
site binding reaction:
C ¼ L  Rmax
KD þ L
where C is the total number of receptor–ligand complexes (measured), L
is the radioligand concentration, Rmax is the total number of active recep-
tors, and KD is the equilibrium dissociation constant. The coefﬁcients for
KD and Rmax were determined by averaging the minimized least square
regression for the data of each experiment. The standard error of the
mean (SEM) and 95% conﬁdence intervals were determined from the
sample standard deviation, calculated from at least six independent
experiments.
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